These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1546627)

  • 1. New OTC drugs: a selected review.
    Popovich NG; Newton GD; Pray WS
    Am Pharm; 1992 Feb; NS32(2):26-7, 37-8. PubMed ID: 1546627
    [No Abstract]   [Full Text] [Related]  

  • 2. New OTC drugs and devices: a selected review.
    Newton GD; Pray WS; Popovich NG
    Am Pharm; 1995 Feb; NS35(2):35-46. PubMed ID: 7900651
    [No Abstract]   [Full Text] [Related]  

  • 3. New OTCs: a selected review.
    Newton GD; Pray WS; Popovich NG
    Am Pharm; 1994 Feb; NS34(2):31-38; 40. PubMed ID: 8166043
    [No Abstract]   [Full Text] [Related]  

  • 4. OTC labeling reform.
    J Am Pharm Assoc (Wash); 1997; NS37(6):619-20. PubMed ID: 9425787
    [No Abstract]   [Full Text] [Related]  

  • 5. New directions in OTC drug labeling.
    Kerner GH
    Drug Inf J; 1978; 12(1):45-50. PubMed ID: 10308105
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA considers OTC drug labeling reform.
    Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722
    [No Abstract]   [Full Text] [Related]  

  • 7. User-friendly labeling for OTC drugs.
    Chase SL
    RN; 1999 Jul; 62(7):93. PubMed ID: 10446641
    [No Abstract]   [Full Text] [Related]  

  • 8. New OTC drug facts label.
    FDA Consum; 2002; 36(4):35. PubMed ID: 12184303
    [No Abstract]   [Full Text] [Related]  

  • 9. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
    Moxley JH; Yingling GL; Edwards CC
    Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
    [No Abstract]   [Full Text] [Related]  

  • 10. New warning issued on OTC analgesics.
    Chase SL
    RN; 1999 Mar; 62(3):93. PubMed ID: 10205570
    [No Abstract]   [Full Text] [Related]  

  • 11. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA rethinks OTC status of bronchodilators, theophylline labeling.
    Am J Health Syst Pharm; 1995 Oct; 52(20):2180. PubMed ID: 8564586
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA Promotes Safe Use of OTC Medications.
    Aschenbrenner DS
    Am J Nurs; 2017 Mar; 117(3):24-25. PubMed ID: 28230687
    [No Abstract]   [Full Text] [Related]  

  • 14. Finally, the final rule on OTC sunscreen drug products.
    DeLeo VA
    Cutis; 2011 Oct; 88(4):163. PubMed ID: 22106719
    [No Abstract]   [Full Text] [Related]  

  • 15. New OTC drugs and devices: a selective review.
    Newton GD; Pray WS; Popovich NG
    J Am Pharm Assoc (Wash); 1997; NS37(2):165-76. PubMed ID: 9069690
    [No Abstract]   [Full Text] [Related]  

  • 16. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA investigating nonprescription cough and cold products.
    Traynor K
    Am J Health Syst Pharm; 2007 Apr; 64(8):802-3. PubMed ID: 17420190
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient information--the time is now.
    Penna RP
    Am Pharm; 1979 Nov; 19(12):5. PubMed ID: 517416
    [No Abstract]   [Full Text] [Related]  

  • 19. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA panel vetoes OTC version of cholesterol drug.
    Walczak IM
    Diabetes Technol Ther; 2000; 2(3):484. PubMed ID: 11467353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.